Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.